Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions
Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations
  • Birmingham Heartlands Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Beatson Hospital Glasgow, United Kingdom
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT04052997

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Health - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 73 locations
View Trial Details
Completed

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

NCT04478123

Conditions
Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions